[
    [
        {
            "time": "",
            "original_text": "医药生物行业研究周报：建议以中期维度看医药行情",
            "features": {
                "keywords": [
                    "医药",
                    "生物",
                    "中期",
                    "行情"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业研究周报：建议以中期维度看医药行情",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "CXO2020年报及2021一季报总结：CXO向好 CDMO行业进入加速期",
            "features": {
                "keywords": [
                    "CXO",
                    "CDMO",
                    "加速期",
                    "年报",
                    "季报"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "CXO2020年报及2021一季报总结：CXO向好 CDMO行业进入加速期",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "泡沫？国内CXO巨头营收仅为昆泰的1/4，市值却位列全球第一，凭什么？",
            "features": {
                "keywords": [
                    "泡沫",
                    "CXO",
                    "营收",
                    "市值"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "泡沫？国内CXO巨头营收仅为昆泰的1/4，市值却位列全球第一，凭什么？",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "医疗板块继续走弱，医疗ETF今年以来份额增长近40亿份",
            "features": {
                "keywords": [
                    "医疗",
                    "板块",
                    "走弱",
                    "ETF",
                    "份额增长"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医疗板块继续走弱，医疗ETF今年以来份额增长近40亿份",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【牛人重仓】药明康德:15日、30日、60日、120日融资余额增仓形成共振，今日资金流入-5557.75万元，北向资金持股15005.93万股，融资余额352634.16万元；前3个交易日，北向资金增持19.51万股，融资额增加-1871.0万元，主力资金净流入-32763.49万元",
            "features": {
                "keywords": [
                    "药明康德",
                    "融资余额",
                    "北向资金",
                    "主力资金",
                    "增仓"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【牛人重仓】药明康德:15日、30日、60日、120日融资余额增仓形成共振，今日资金流入-5557.75万元，北向资金持股15005.93万股，融资余额352634.16万元；前3个交易日，北向资金增持19.51万股，融资额增加-1871.0万元，主力资金净流入-32763.49万元",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【牛人重仓】药明康德:牛人重仓绩优股今年以来融资余额增仓100%以上，今日资金流入-1409.97万元，北向资金持股15005.93万股，融资余额352634.16万元；前3个交易日，北向资金增持19.51万股，融资额增加-1871.0万元，主力资金净流入-32763.49万元",
            "features": {
                "keywords": [
                    "药明康德",
                    "融资余额",
                    "北向资金",
                    "主力资金",
                    "增仓"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【牛人重仓】药明康德:牛人重仓绩优股今年以来融资余额增仓100%以上，今日资金流入-1409.97万元，北向资金持股15005.93万股，融资余额352634.16万元；前3个交易日，北向资金增持19.51万股，融资额增加-1871.0万元，主力资金净流入-32763.49万元",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "明日下午3点！高通量和高内涵药物筛选——点亮新靶点的药物研发里程",
            "features": {
                "keywords": [
                    "高通量",
                    "高内涵",
                    "药物筛选",
                    "新靶点",
                    "研发"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "明日下午3点！高通量和高内涵药物筛选——点亮新靶点的药物研发里程",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]